Genor Biopharma Holdings Limited Share Price

Equities

6998

KYG3871A1004

Biotechnology & Medical Research

Market Closed - Hong Kong S.E. 01:38:35 13/05/2024 pm IST 5-day change 1st Jan Change
1.42 HKD +1.43% Intraday chart for Genor Biopharma Holdings Limited +13.60% +19.33%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site

Financials

Sales 2021 - Sales 2022 15.93M 2.2M 17.2M 184M Capitalization 1.17B 162M 1.27B 13.53B
Net income 2021 -865M -120M -934M -9.98B Net income 2022 -730M -101M -788M -8.42B EV / Sales 2021 -
Net cash position 2021 2.14B 296M 2.31B 24.73B Net cash position 2022 1.56B 216M 1.68B 18B EV / Sales 2022 -24.3 x
P/E ratio 2021
-3.28 x
P/E ratio 2022
-1.62 x
Employees 104
Yield 2021 *
-
Yield 2022
-
Free-Float 66.07%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.43%
1 week+13.60%
Current month+13.60%
1 month+18.33%
3 months+52.69%
6 months+2.16%
Current year+19.33%
More quotes
1 week
1.16
Extreme 1.16
1.50
1 month
1.03
Extreme 1.03
1.50
Current year
0.85
Extreme 0.85
1.50
1 year
0.85
Extreme 0.85
1.99
3 years
0.85
Extreme 0.85
19.00
5 years
0.85
Extreme 0.85
32.20
10 years
0.85
Extreme 0.85
32.20
More quotes
Date Price Change Volume
13/24/13 1.42 +1.43% 447 618
10/24/10 1.4 +0.72% 160,000
09/24/09 1.39 +4.51% 631,000
08/24/08 1.33 +7.26% 279,000
07/24/07 1.24 +5.98% 573,000

Delayed Quote Hong Kong S.E., May 13, 2024 at 01:38 pm IST

More quotes
Genor Biopharma Holdings Ltd, formerly JHBP CY Holdings Ltd, is China-based company mainly engaged in the research and development of biopharmaceutical products. The Company focuses on the development and commercialization of oncology and autoimmune drugs. The Company's main drugs include lerociclib (GB491), coprelotamab (GB221), geptanolimab (GB226), GB492, GB242 and GB223. The Company mainly conducts its businesses in the China market.
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW